P

Inventor

MAZAR ANDREW P

US11 patents
⚠️ This page may combine multiple inventors who share the name “MAZAR ANDREW P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ANGSTROM PHARMACEUTICALS INC

6 patents
US7807621B2Oct 5, 2010

Anti-invasive and anti-angiogenic compositions

ANGSTROM PHARMACEUTICALS INC34 citations94
US6277818B1Aug 21, 2001

Cyclic peptide ligands that target urokinase plasminogen activator receptor

ANGSTROM PHARMACEUTICALS INC36 citations91
US5994309ANov 30, 1999

Anti-invasive and anti-angiogenic compositions and methods

ANGSTROM PHARMACEUTICALS INC26 citations91
US6896870B1May 24, 2005

Diagnostic probes and therapeutics targeting uPA and uPAR

ANGSTROM PHARMACEUTICALS INC9 citations72
US6696416B1Feb 24, 2004

Anti-invasive and anti-angiogenic compositions

ANGSTROM PHARMACEUTICALS INC11 citations72
US6936587B1Aug 30, 2005

Anti-invasive and anti-angiogenic compositions

ANGSTROM PHARMACEUTICALS INC3 citations61

ATTENUON LLC

2 patents
US7119069B2Oct 10, 2006

Human kininogen D3 domain polypeptide as an anti-angiogenic and anti-tumor agent

ATTENUON LLC0 citations47
US7098187B2Aug 29, 2006

Human kininogen D3 domain polypeptide as an anti-angiogenic and anti-tumor agent

ATTENUON LLC0 citations47

PARRY GRAHAM C

1 patent
US8101726B2Jan 24, 2012

Ligands binding the complex of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) that inhibit downstream uPAR interactions: identification and use in diagnosis or therapy

PARRY GRAHAM C14 citations72

PARRY GRAHAM

1 patent
US8105602B2Jan 31, 2012

Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof

PARRY GRAHAM5 citations57

MAZAR ANDREW P

1 patent
US8110543B2Feb 7, 2012

Anti-invasive and anti-angiogenic compositions

MAZAR ANDREW P0 citations40